|
?:authorAffiliation
|
-
[\'IFCC Taskforce on COVID-19, International Federation of Clinical Chemistry and Laboratory Medicine, Milan, Italy.\', \'Section of Clinical Biochemistry, Department of Neuroscience, Biomedicine and Movement, University Hospital of Verona, University of Verona, Piazzale L.A. Scuro, 10, 37134 Verona, Italy.\', \'Clinical Biochemistry, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.\', \'Vita-Salute San Raffaele University, Milan, Italy.\', \'Department of Clinical Chemistry and Endocrinology, New South Wales Health Pathology, Prince of Wales Hospital, Sydney, Australia.\', \'Department of Pathology and Laboratory Medicine, Emory University, and Director of Clinical Chemistry, Grady Memorial Hospital, Atlanta, GA, USA.\', \'Department of Laboratory Medicine, National University Hospital, Singapore, Singapore.\', \'Department of Laboratory Medicine, Chinese PLA General Hospital, Beijing, P.R. China.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}